Due for re-check: the scheduled review date of 2026-09-04 has passed. Every value below still carries the source it was taken from and the passage that states it — check it against the link.
0703-3675-01 · Methotrexate Sodium Injection · Teva Pharmaceuticals USA, Inc.
What is the package ndc for 0703-3675-01 · Methotrexate Sodium Injection · Teva Pharmaceuticals USA, Inc.?
For 0703-3675-01 · Methotrexate Sodium Injection · Teva Pharmaceuticals USA, Inc., package ndc is 0703-3675-01; generic name is Methotrexate Sodium Injection; manufacturer is Teva Pharmaceuticals USA, Inc; status is Current; availability now is Unavailable, recorded from its source on 2026-09-01.
"initial_posting_date": "03/13/2023", "package_ndc": "0703-3675-01", "generic_name": "Methotrexate Sodium Injection", "contact_info": "800-545-8800", "availability": "Unavailable", "related_info": "Estimated recovery: December 2026"
— api.fda.gov, retrieved 2026-09-01
- Package NDC
- 0703-3675-01 verified
- Generic name
- Methotrexate Sodium Injection verified
- Manufacturer
- Teva Pharmaceuticals USA, Inc. verified
- Status
- Current verified
- Availability now
- Unavailable verified
- FDA note
- Estimated recovery: December 2026 verified
- Initial posting date
- 03/13/2023 verified
- Last update date
- 08/17/2026 verified
- Days in shortage
- 1268 our reading
- Reason for shortage
- Other verified
- Dosage form
- Injection verified
- Therapeutic category
- Rheumatology verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "08/17/2026", "therapeutic_category": [ "Rheumatology", "Oncology" ], "dosage_form": "Injection", "presentation": "Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3675-01)", "company_name": "Teva Pharmaceuticals USA, Inc.", "shortage_reason": "Other", "status": "Current"
— all from api.fda.gov, retrieved 2026-09-01
The same source also states
"initial_posting_date": "03/13/2023", "package_ndc": "0703-3675-01", "generic_name": "Methotrexate Sodium Injection", "contact_info": "800-545-8800", "availability": "Limited Availability", "related_info": "Estimated recovery: December 2026"
— api.fda.gov, retrieved 2026-09-03
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000